: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Drug Resistance

Free Subscription

Articles published in J Antimicrob Chemother
Retrieve available abstracts of 445 articles:
HTML format

Single Articles

August 2026

DINATA R, Baindara P, Chakraborty S, Mondal S, et al
Mutation-driven alterations in the AcrB efflux pump modulate antibiotic resistance in Klebsiella pneumoniae.
J Antimicrob Chemother. 2026;81:dkag270.
PubMed Abstract available

GONCALVES O, Cote JP
Genome-wide network of antibiotic susceptibility in Pseudomonas aeruginosa.
J Antimicrob Chemother. 2026;81:dkag272.
PubMed Abstract available

PAOPANG P, Sangprasert P, Golparian D, Girdthep N, et al
Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018-23.
J Antimicrob Chemother. 2026;81:dkag260.
PubMed Abstract available

SHAH S, Clarke LG, Kline EG, Marini RV, et al
Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales.
J Antimicrob Chemother. 2026;81:dkag267.
PubMed Abstract available

PORTAIS A, Lastere S, Boutolleau D
Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient.
J Antimicrob Chemother. 2026;81:dkag275.
PubMed

BELLECAVE P, Peyrouny-Mazeau A, Leleux O, Hessamfar M, et al
Factors associated with virological failure in people with HIV treated with bictegravir/emtricitabine/tenofovir alafenamide. Impact of pre-existing mutations and risk of resistance emergence. ANRS-CO3-AquiVIH-NA cohort.
J Antimicrob Chemother. 2026;81:dkag278.
PubMed Abstract available

FREIRE S, Alvarez SM, Findlay J, Vogel M, et al
Characterization of the intrinsic AmpC beta-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins.
J Antimicrob Chemother. 2026;81:dkag271.
PubMed Abstract available

ROUABAH L, Ronsin S, Vasseur A, Rezzoug I, et al
Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.
J Antimicrob Chemother. 2026;81:dkag273.
PubMed Abstract available

BOSNAK C, Metan G, Zarakolu P, Karakulak EA, et al
Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment.
J Antimicrob Chemother. 2026;81:dkag284.
PubMed Abstract available

PHAM TH, Ngo HTH, Pham TTP, Le NTH, et al
Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples.
J Antimicrob Chemother. 2026;81:dkag279.
PubMed Abstract available

July 2026

VICKERS A, Day M, Doumith M, Vivekanand S, et al
Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting.
J Antimicrob Chemother. 2026;81:dkag211.
PubMed Abstract available

DRUMEL T, Kimmerlin J, Allavena C, Deschanvres C, et al
Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study.
J Antimicrob Chemother. 2026;81:dkag247.
PubMed Abstract available

SOULIE C, Zafilaza K, Wirden M, Sayon S, et al
Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation.
J Antimicrob Chemother. 2026;81:dkag245.
PubMed Abstract available

WILKINSON DA, Sellier A, Maurines-Carboneill C, Etheves A, et al
Characterization of IMI-4 carbapenemase-producing Enterobacter sp. isolated from humans and a companion animal in French Indian Ocean territories.
J Antimicrob Chemother. 2026;81:dkag243.
PubMed Abstract available

ZHANG S, Li Y, Tan H, Li Y, et al
Effect of adjunctive inhalation on the association between plasma AUC/MIC of polymyxin B and clinical efficacy in MDR gram-negative infections.
J Antimicrob Chemother. 2026;81:dkag238.
PubMed Abstract available

PELTONEN N, Sealey JE, Mounsey O, Best CM, et al
Genomic analyses of antibiotic-resistant Escherichia coli from extensive beef cattle and sheep farms identifies inter-species and farm-farm sharing as clonal dissemination pathways.
J Antimicrob Chemother. 2026;81:dkag241.
PubMed Abstract available

LIN SY, Tseng YT, Abdrabo KAE, Wu HM, et al
Antifungal susceptibility profiles of clinical and environmental Scedosporium and Lomentospora isolates from Taiwan: focus on olorofim activity and phylogenetic heterogeneity.
J Antimicrob Chemother. 2026;81:dkag236.
PubMed Abstract available

PEARCE R, Pirolo M, Ma Y, Graf FE, et al
Identification of novel plasmid-mediated colistin resistance gene mcr-11.1 in Enterobacter mori isolated from seafood.
J Antimicrob Chemother. 2026;81:dkag251.
PubMed Abstract available

BOGLIONE-KERRIEN C, Lemaitre F, Gautier-Veyret E, Baklouti S, et al
Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole?
J Antimicrob Chemother. 2026;81:dkag231.
PubMed Abstract available

REN J, Zhang M, Wu J, Li Y, et al
MALDI-TOF mass spectrometry and SHAP guided machine learning for multicenter antibiotic resistance prediction in Pseudomonas aeruginosa.
J Antimicrob Chemother. 2026;81:dkag259.
PubMed Abstract available

June 2026

MUTURI C, Wu A, McShea K, Redding LE, et al
Quantifying household-level sharing of antimicrobial-resistant pathogens between pets and their owners: a systematic review and meta-analysis.
J Antimicrob Chemother. 2026;81:dkag195.
PubMed Abstract available

LI G, El-Deeb IM, Whyte HG, Blaskovich MAT, et al
Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus.
J Antimicrob Chemother. 2026;81:dkag186.
PubMed Abstract available

ABRAHAM S, Lee ZZ, Jordan D, Stegger M, et al
High-resolution characterization of the temporal and spatial distribution of antimicrobial resistance in Escherichia coli from pigs.
J Antimicrob Chemother. 2026;81:dkag196.
PubMed Abstract available

SPEERS DJ, Minney-Smith C, Simpson H, Rhodes M, et al
Molecular surveillance of penicillinase-producing Neisseria gonorrhoeae to inform empiric treatment in remote settings: experience over 12 years.
J Antimicrob Chemother. 2026;81:dkag197.
PubMed Abstract available

PAGANINI JA, Schurch AC, Scharringa J, Bonten MJM, et al
Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.
J Antimicrob Chemother. 2026;81:dkag223.
PubMed Abstract available

CALVEZ V, Charpentier C, Alidjinou EK, Wirden M, et al
Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.
J Antimicrob Chemother. 2026;81:dkag191.
PubMed Abstract available

HUGG R, Stegger M, Soderquist B
Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.
J Antimicrob Chemother. 2026;81:dkag218.
PubMed Abstract available

May 2026

CASTAGNOLA E, Mariani M, Saffioti C, Ricci E, et al
Artificial intelligence for analysing antibiotic use: an exploratory study in a tertiary care paediatric hospital in Italy.
J Antimicrob Chemother. 2026;81:dkag162.
PubMed Abstract available

KONG J, Yao Z, Zheng Y, Zhang J, et al
Antimicrobial activity of aztreonam-avibactam against KPC variant-producing Klebsiella pneumoniae with ceftazidime-avibactam resistance.
J Antimicrob Chemother. 2026;81:dkag152.
PubMed Abstract available

WAJIMA T, Kubota T, Tanaka E, Hirata A, et al
Highly transformable Haemophilus influenzae as a potential amplifier of quinolone resistance dissemination.
J Antimicrob Chemother. 2026;81:dkag160.
PubMed Abstract available

DRAKE S, Leininger J, Bazan JA, Coe K, et al
High-dose daptomycin for the treatment of invasive infections due to Enterococcus faecalis isolates with intermediate susceptibility.
J Antimicrob Chemother. 2026;81:dkag179.
PubMed Abstract available

KANG W, Kang W, Son Y, Kim J, et al
Temporal association between aerosolized colistin use and colistin resistance in the ICU: a time-series analysis.
J Antimicrob Chemother. 2026;81:dkag169.
PubMed Abstract available

ALANBARI N, Amoura A, Guerin F, Cosson G, et al
Temocillin efficacy and emergence of resistance in Enterobacter cloacae Complex in a murine peritonitis model.
J Antimicrob Chemother. 2026;81:dkag151.
PubMed Abstract available

LOU L, Xiao Y, Wang L, Li X, et al
Population pharmacokinetic analysis and dosing regimen optimization of eravacycline in critically ill patients with carbapenem-resistant Acinetobacter baumannii pneumonia.
J Antimicrob Chemother. 2026;81:dkag178.
PubMed Abstract available

CRESTANI C, Bremont S, Barbet M, Museux K, et al
Macrolide resistance via 23S rRNA gene mutation in Corynebacterium ulcerans.
J Antimicrob Chemother. 2026;81:dkag166.
PubMed

HALDORSEN BC, Augustinussen MH, Matuschek E, Smabrekke L, et al
Performance of EUCAST disc diffusion and supplementary methods to detect reduced susceptibility to linezolid in enterococci- the NordicAST LRE-study.
J Antimicrob Chemother. 2026;81:dkag174.
PubMed Abstract available

CANTON R, Garcia-Castillo M, Hernandez-Garcia M, Sastre-Femenia MA, et al
Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes.
J Antimicrob Chemother. 2026;81:dkag164.
PubMed Abstract available

TUROWSKI P, Cremanns M, Pfennigwerth N, Gatermann SG, et al
Influence of a putative TonB-dependent receptor on cefiderocol susceptibility in clinical Enterobacter hormaechei isolates.
J Antimicrob Chemother. 2026;81:dkag193.
PubMed Abstract available

YANG J, Shi T, Du Z, Wang Y, et al
Sub-inhibitory polyether ionophores enhance resistance plasmid transfer and transiently perturb the broiler gut resistome.
J Antimicrob Chemother. 2026;81:dkag190.
PubMed Abstract available

LASRY D, Harrison LB, Bamba R, Corsini R, et al
In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA).
J Antimicrob Chemother. 2026;81:dkag182.
PubMed Abstract available

April 2026

OKANDA T, Nakajima N, Yamaguchi T, Koshikawa T, et al
In vitro synergistic activity of minocycline and biapenem against cefiderocol-resistant New Delhi metallo-beta-lactamase-producing Enterobacterales.
J Antimicrob Chemother. 2026;81:dkag128.
PubMed Abstract available

PIROLO M, Abuoun M, Duggett N, Haenni M, et al
Cross-species and cross-border spread of aph(3')-ia-mediated neomycin resistance in Escherichia coli from animals: a genomic perspective.
J Antimicrob Chemother. 2026;81:dkag143.
PubMed Abstract available

CHEN J, Liang G
Genome-wide association studies builds a predictive model and reveals novel resistance features for macrolide-resistant Bordetella pertussis.
J Antimicrob Chemother. 2026;81:dkag131.
PubMed Abstract available

YANG K, Zhang T, Geng J, Long J, et al
Molecular mechanism of envZ regulating beta-lactam antibiotic resistance and virulence in Escherichia coli.
J Antimicrob Chemother. 2026;81:dkag104.
PubMed Abstract available

CANAS MA, Garcia-Gonzalez J, Luque-Paz D, Cuervo G, et al
In vitro and in vivo activity of daptomycin plus ceftaroline for the treatment of experimental endocarditis due to Enterococcus faecalis with and without high-level aminoglycoside resistance.
J Antimicrob Chemother. 2026;81:dkag136.
PubMed Abstract available

GOMEZ LONDONO LF, Souza ACO, Burt B, Das S, et al
Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance.
J Antimicrob Chemother. 2026;81:dkag124.
PubMed Abstract available

TUROWSKI P, Gatermann SG, Pfennigwerth N
Cefiderocol resistance mediated by mutation of the miniconductance mechanosensitive channel MscM in Klebsiella oxytoca.
J Antimicrob Chemother. 2026;81:dkag147.
PubMed Abstract available

ROSS P, Acuna MP, Carcamo-Oyarce G, Arancibia JM, et al
MRSA and carbapenem-resistant Acinetobacter baumannii on the fall: successful infection prevention and control in Chilean ICUs.
J Antimicrob Chemother. 2026;81:dkag146.
PubMed

March 2026

PAUW HS, Schwarz R, Beij A, Sieswerda E, et al
Antimicrobial therapy for infected necrotizing pancreatitis: microbiology, antimicrobial resistance and pharmacokinetics.
J Antimicrob Chemother. 2026;81:dkag092.
PubMed Abstract available

SCHONENBERGER CM, Haenggi K, Ringera IK, Luoga E, et al
HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial.
J Antimicrob Chemother. 2026;81:dkag070.
PubMed Abstract available

KOIZUMI J, Otake R, Seyama S, Hayashi N, et al
Functional analysis of a novel macrolide-lincosamide resistance gene erm(57) in Cutibacterium avidum.
J Antimicrob Chemother. 2026;81:dkag029.
PubMed Abstract available

GRAZIANI L, Giani T, Farese A, Di Lauria N, et al
Vancomycin resistance predicts increased mortality in patients with Enterococcus faecium bloodstream infections: a six-year experience at a large tertiary care Italian hospital.
J Antimicrob Chemother. 2026;81:dkag069.
PubMed Abstract available

WAN L, Li X, Zheng X, Chen T, et al
Genomic insights into the tmexCD-toprJ: plasmid-mediated evolution, dissemination and diversity in bacterial populations.
J Antimicrob Chemother. 2026;81:dkag107.
PubMed Abstract available

BEH JQ, Howden BP, Webb JR, Connor CH, et al
Global dissemination of optrA-mediated linezolid resistance in enterococci.
J Antimicrob Chemother. 2026;81:dkag089.
PubMed Abstract available

DAMSTE C, Stoorvogel H, Oerlemans A, Knippenberg M, et al
Healthcare providers' experiences in caring for MDRO carriers with a focus on the moral dimensions of care: a systematic review.
J Antimicrob Chemother. 2026;81:dkag059.
PubMed Abstract available

YAO H, Li W, Chen M, Zhang C, et al
Characterization of efflux pump channel of florfenicol for resistance-enhancing variant RE-CmeABC in Campylobacter.
J Antimicrob Chemother. 2026;81:dkag047.
PubMed Abstract available

SANCAK B, Kirbas E, Ari O, Durmaz R, et al
Genomic characterization of colistin heteroresistance in Acinetobacter baumannii: Evidence for lpxD deletion and collateral sensitivity.
J Antimicrob Chemother. 2026;81:dkag076.
PubMed Abstract available

ARMENIA D, Alteri C, Micheli V, Allice T, et al
Evaluation of HIV-1 transmitted drug-resistance among subtypes circulating from 2022 to 2024 in Italy: a refined analysis through next-generation sequencing.
J Antimicrob Chemother. 2026;81:dkag084.
PubMed Abstract available

RU S, Zhang Y
Comment on: Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched-cohort study.
J Antimicrob Chemother. 2026;81:dkag096.
PubMed

VAN DEN BERG S, Attwood M, Griffin P, Noel A, et al
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions.
J Antimicrob Chemother. 2026;81:dkag106.
PubMed Abstract available

INCIARTE A, Berrocal L, Santos JR, Aleman MR, et al
Baseline resistance mutations and virological response to dolutegravir in treatment-naive patients: a multicentre NGS study.
J Antimicrob Chemother. 2026;81:dkag080.
PubMed Abstract available

HAN N, Loosli T, Sauermann M, Celikag I, et al
Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study.
J Antimicrob Chemother. 2026;81:dkag088.
PubMed Abstract available

PIQUART L, Goutelle S, Maillard M, Boisset S, et al
Temocillin: a therapeutic alternative in bone and joint infections due to third generation cephalosporin-resistant Enterobacterales?
J Antimicrob Chemother. 2026;81:dkag105.
PubMed Abstract available

XU Q, Zhu Y, Schwarz S, Xie S, et al
Characterization of a ST412-K57 colistin-resistant hypervirulent Klebsiella pneumoniae strain of chicken origin.
J Antimicrob Chemother. 2026;81:dkag114.
PubMed Abstract available

LU TY, Wu SJ, Chu YF, Ni XB, et al
Outer membrane vesicles transmit blaNDM-5 and package metallo-beta-lactamases to promote antibiotic resistance in Escherichia coli.
J Antimicrob Chemother. 2026;81:dkag123.
PubMed Abstract available

PLAINVERT C, Poyart C, Tazi A, Mammeri H, et al
Contribution of SHV-1 overexpression to carbapenem resistance in a Klebsiella pneumoniae clinical isolate.
J Antimicrob Chemother. 2026;81:dkag108.
PubMed

February 2026

KARAKONSTANTIS S, Tziolos RN, Paneta M, Kritsotakis EI, et al
Global and regional prevalence of metallo-beta-lactamases in carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
J Antimicrob Chemother. 2026;81:dkag037.
PubMed Abstract available

THORINGTON R, Barairo N, Peterson SW, Lourenco L, et al
Summary of ceftriaxone-resistant Neisseria gonorrhoeae in Canada, 2017-24.
J Antimicrob Chemother. 2026;81:dkag007.
PubMed Abstract available

VAN OSCH JAT, Voermans JJC, Ouzerne H, Cromme ABH, et al
Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failure.
J Antimicrob Chemother. 2026;81:dkag033.
PubMed Abstract available

Correction to: Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.
J Antimicrob Chemother. 2026;81:dkaf494.
PubMed

ELBUR AI, Gandla S, Nakka R, Khan R, et al
Nationwide patterns of HIV drug resistance and high viral load in Sub-Saharan African countries.
J Antimicrob Chemother. 2026;81:dkaf497.
PubMed Abstract available

CHEN S, Wei Y, Wang Q, Li Y, et al
Antifungal susceptibility surveillance of clinical moulds to olorofim, manogepix, amphotericin B, triazoles and echinocandins at 10 tertiary hospitals in China (2019-24).
J Antimicrob Chemother. 2026;81:dkag016.
PubMed Abstract available

XIA X, Ge M, Chen J, Qian X, et al
LYSC98 as a novel vancomycin-derived agent effective against antibiotic-resistant pathogens in tolerant state.
J Antimicrob Chemother. 2026;81:dkag036.
PubMed Abstract available

CIACCIO L, Donnan PT, Parcell BJ, Marwick CA, et al
Impact of COVID-19-related healthcare changes on antibiotic resistance in clinical Escherichia coli isolates: interrupted time series analyses in Scotland, UK.
J Antimicrob Chemother. 2026;81:dkag049.
PubMed Abstract available

ROTUNDO S, Russo A, Morena R, Garofalo E, et al
Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study.
J Antimicrob Chemother. 2026;81:dkag056.
PubMed Abstract available

KIM SH, Kim HM, Chung DR, Ko JH, et al
In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
J Antimicrob Chemother. 2026;81:dkag031.
PubMed Abstract available

FAN Y, Liang X, Ren Y, Nie S, et al
A two-stage diagnostic model for discriminating and assessing risk of meropenem heteroresistance in Pseudomonas aeruginosa.
J Antimicrob Chemother. 2026;81:dkag061.
PubMed Abstract available

PEZZATI L, Conti F, Gennari W, Mussini C, et al
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes.
J Antimicrob Chemother. 2026;81:dkag035.
PubMed Abstract available

ISLAM R, Das SC, Pletzer D
Combating multidrug-resistant Klebsiella pneumoniae: current therapeutic regimens and future directions.
J Antimicrob Chemother. 2026;81:dkag064.
PubMed Abstract available

QIN L, Xie Y, Li J, Zhong G, et al
Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China.
J Antimicrob Chemother. 2026;81:dkag073.
PubMed Abstract available

January 2026

COLE MJ, Doumith M, Vickers A, Alexander S, et al
In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates.
J Antimicrob Chemother. 2026;81:dkag001.
PubMed Abstract available

CHEN GJ, Lee NY, Tsai MS, Huang SH, et al
Resistance to second-generation integrase inhibitors in people with HIV following treatment failure on dolutegravir- or bictegravir-based ART in Taiwan.
J Antimicrob Chemother. 2026;81:dkaf488.
PubMed Abstract available

SWEENEY EL, Tickner JA, Ertl NG, Bauer MJ, et al
Rapid molecular diagnostics for detection of extensively drug-resistant Salmonella Typhi.
J Antimicrob Chemother. 2026;81:dkaf481.
PubMed Abstract available

WU M, Li J, Zhou Z, Chen Y, et al
Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae.
J Antimicrob Chemother. 2026;81:dkaf504.
PubMed Abstract available

STURM PDJ, Van Niekerk JM, Lestrade PPA, Peters CJA, et al
Prevalence of macrolide resistance in Mycoplasma pneumoniae in The Netherlands.
J Antimicrob Chemother. 2026;81:dkaf475.
PubMed Abstract available

DWIBEDY SK, Padhy I, Mohapatra SS
A comprehensive analysis of the mutational landscape determining polymyxin resistance in Klebsiella pneumoniae.
J Antimicrob Chemother. 2026;81:dkaf503.
PubMed Abstract available

ZHUO J, Xu J, Chi Y, Zhang N, et al
Ceftazidime/avibactam: a potent arsenal against multidrug-resistant Pseudomonas aeruginosa-unveiling in vitro and in vivo strategies.
J Antimicrob Chemother. 2026;81:dkaf495.
PubMed Abstract available

MIELKO-NIZIALEK KA, Jablonski S, Wisniewski J, Milczewska J, et al
Antibiotic resistance of Pseudomonas aeruginosa strains-intracellular metabolomics analysis.
J Antimicrob Chemother. 2026;81:dkaf453.
PubMed Abstract available

SAAD BAA, Volpe-Chaves CE, de Oliveira CTF, Conte BS, et al
The emerging clinical relevance and antimicrobial resistance of Pluralibacter gergoviae: a systematic review.
J Antimicrob Chemother. 2026;81:dkaf476.
PubMed Abstract available

TASCINI C, Bianco G, Bonomo RA, Gaibani P, et al
In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates.
J Antimicrob Chemother. 2026;81:dkaf467.
PubMed Abstract available

MCCRACKEN M, Lerminiaux N, Adam HJ, Baxter M, et al
Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.
J Antimicrob Chemother. 2026;81:dkaf478.
PubMed Abstract available

ZHANG X, Xie Y, Liu F, Cheng Z, et al
Simulated lung exposure in pneumonia patients to evaluate the antibacterial capacity and resistance suppression of clinical tigecycline regimens against carbapenem-resistant Acinetobacter baumannii.
J Antimicrob Chemother. 2026;81:dkaf477.
PubMed Abstract available

TU NQ, Montrouge T, Mbemba G, Stampetta M, et al
First characterization of insertions in the HIV-1 integrase-coding region from people with HIV.
J Antimicrob Chemother. 2026;81:dkaf491.
PubMed Abstract available

YAMANO Y, Takemura M, Longshaw C, DeJonge BLM, et al
Understanding mechanisms of reduced cefiderocol susceptibility in pvdS and fecI mutants of Pseudomonas aeruginosa.
J Antimicrob Chemother. 2026;81:dkag004.
PubMed Abstract available

LI Y, Dong H, Liu X, Shen Y, et al
IS26-mediated chromosomal integration of virulence plasmid fragments in ST2237 carbapenem-resistant Klebsiella pneumoniae.
J Antimicrob Chemother. 2026;81:dkag018.
PubMed

MARTINEZ-BUITRAGO E, Zapata-Marin AF, Rubiano LC, Sanudo LM, et al
National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing.
J Antimicrob Chemother. 2026;81:dkaf444.
PubMed Abstract available

AHLSTRAND J, Maatouk I, Doanh LH, Girdthep N, et al
High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24.
J Antimicrob Chemother. 2026;81:dkaf452.
PubMed Abstract available

MONTERO MM, Fernandez-Munoz A, Domene-Ochoa S, Castaneda S, et al
Preventing resistance development in infections by OXA beta-lactamase-producing Pseudomonas aeruginosa: correlating clinical outcomes with hollow-fibre model input.
J Antimicrob Chemother. 2026;81:dkaf464.
PubMed Abstract available

KAPAATA A, Byamukama D, Kankaka EN, Asio JN, et al
HIV-1 drug resistance among pregnant and breastfeeding mothers and its association with paediatric HIV infections in the Dolutegravir era in Uganda.
J Antimicrob Chemother. 2026;81:dkaf411.
PubMed Abstract available

MELNYCHUK S, Thompson LH, Archibald C, Blanchard JF, et al
Notable transmitted HIV drug resistance among people who inject drugs in Pakistan.
J Antimicrob Chemother. 2026;81:dkaf425.
PubMed Abstract available

RAAIJMAKERS J, Aarnoutse R, Te Brake L, Stemkens R, et al
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system.
J Antimicrob Chemother. 2026;81:dkaf402.
PubMed Abstract available

MUDDE SE, Meliefste HM, Klaassen CHW, Ammerman NC, et al
Omadacycline as a drug candidate for Mycobacterium avium infections: in vitro insights on single and combination therapies.
J Antimicrob Chemother. 2026;81:dkaf413.
PubMed Abstract available

SOULIE C, Agher R, Fauchois A, Abdi B, et al
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable.
J Antimicrob Chemother. 2026;81:dkaf454.
PubMed Abstract available

SHAW D, Thakur S, Ghosh A, Dogra S, et al
Efflux-mediated multidrug resistance mechanism in Trichophyton indotineae and Trichophyton rubrum; role of ABC transporters and MFS gene.
J Antimicrob Chemother. 2026;81:dkaf434.
PubMed Abstract available

MOSTAFA R, Mohammed S, Ahmed AS, Aly SA, et al
Nanoparticle-based co-delivery of ciprofloxacin and meropenem enhances synergistic activity against multidrug-resistant hypervirulent Klebsiella pneumoniae clinical isolates.
J Antimicrob Chemother. 2026;81:dkaf422.
PubMed Abstract available

VERMA S, Tilak R, Singh G, Singh S, et al
Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights.
J Antimicrob Chemother. 2026;81:dkaf420.
PubMed Abstract available

ANDERSSON M, Zimmermann N, Kloft C, Aulin LBS, et al
Antibiotic pharmacodynamics: from MIC to advanced metrics and their applications.
J Antimicrob Chemother. 2026;81:dkaf374.
PubMed Abstract available

PALICH R, Ghosn J, Lacombe K, Palacios C, et al
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
J Antimicrob Chemother. 2026;81:dkaf410.
PubMed Abstract available

ZHANG Y, Zhang X, Han S, Wang D, et al
Progress in the study of drug resistance mechanism of Bacillus cereus.
J Antimicrob Chemother. 2026;81:dkaf399.
PubMed Abstract available

ZHU Z, Hua X, Ke Y
Azithromycin resistance in non-typhoidal Salmonella: a review.
J Antimicrob Chemother. 2026;81:dkaf341.
PubMed Abstract available

December 2025

ZHAO R, Wan P, Huang H, Li Q, et al
Harnessing CRISPR-Cas9 and CRISPRi systems to reverse antibiotic resistance in a clinical multidrug-resistant Escherichia coli isolate.
J Antimicrob Chemother. 2025 Dec 24:dkaf442. doi: 10.1093.
PubMed Abstract available

ASIM M, Rizvi SA, Haq QMR
Antiplasmid systems: a novel strategy to combat antibiotic resistance.
J Antimicrob Chemother. 2025 Dec 19:dkaf472. doi: 10.1093.
PubMed Abstract available

KUIL S, Bavalia R, Boyd A, de Jong M, et al
Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study.
J Antimicrob Chemother. 2025 Dec 17:dkaf451. doi: 10.1093.
PubMed Abstract available

CANAS MA, Cuervo G, Garcia-Gonzalez J, Krivak F, et al
In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis.
J Antimicrob Chemother. 2025 Dec 4:dkaf435. doi: 10.1093.
PubMed Abstract available

CHAUVIN C, Jouy E, Chevance A, Jaureguy C, et al
Decrease in colistin resistance among young bovine and pig productions in France: relationship with colistin usage and stewardship measures.
J Antimicrob Chemother. 2025;80:3227-3235.
PubMed Abstract available

ZHANG H, Liang B, Tan Z, Wang R, et al
The synergistic activity of tigecycline-based combinations against multidrug-resistant Acinetobacter baumannii-caused bloodstream infections.
J Antimicrob Chemother. 2025;80:3407-3418.
PubMed Abstract available

VAN RHIJN N, White PL
Antifungal treatment strategies and their impact on resistance development in clinical settings.
J Antimicrob Chemother. 2025;80:3208-3226.
PubMed Abstract available

MULLER SE, Junker S, Rehner J, Forster M, et al
Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa.
J Antimicrob Chemother. 2025;80:3352-3356.
PubMed Abstract available

PELLEGRINO C, Veronese N, De Santis L, Amendolara A, et al
Frailty Index Laboratory (FI-Lab) as predictor of poor outcomes for intra-hospital multidrug-resistant Klebsiella pneumoniae bloodstream infections: a single-centre retrospective cohort study.
J Antimicrob Chemother. 2025;80:3257-3264.
PubMed Abstract available

MORAN RA, Hall RM
The aphA1 kanamycin and neomycin resistance gene originated in Klebsiella michiganensis.
J Antimicrob Chemother. 2025;80:3340-3344.
PubMed Abstract available

CASADO JL, Blanco JL, Izuzquiza I, Moreno A, et al
From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV.
J Antimicrob Chemother. 2025;80:3242-3247.
PubMed Abstract available

BLANCO-MARTIN T, Guzman-Puche J, Hernandez-Garcia M, Munoz-Rosa M, et al
Mechanisms of resistance to ceftazidime/avibactam in mutants derived in vitro from Klebsiella pneumoniae producing OXA-48-like enzymes.
J Antimicrob Chemother. 2025;80:3265-3272.
PubMed Abstract available

SEHGAL N, Pajuelo MJ, Gilman RH, Pickering AJ, et al
Effects of commonly used antibiotics on children's developing gut microbiomes and resistomes in peri-urban Lima, Peru.
J Antimicrob Chemother. 2025;80:3248-3256.
PubMed Abstract available

TANG B, Hu X, Song Y, Liu X, et al
Acquired antimicrobial resistance genes in Bordetella Species: a global genomic analysis.
J Antimicrob Chemother. 2025 Dec 1:dkaf418. doi: 10.1093.
PubMed Abstract available

November 2025

TORUMKUNEY D, Mokaddas E, Weber S, Morrissey I, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Kuwait and the United Arab Emirates: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Van PH, Thinh LQ, Hawser S, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2020-21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Veeraraghavan B, Patil N, Dias M, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in India: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Keles N, Hasdemir U, Hazirolan G, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Turkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Slim L, Hammami A, Hawser S, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Tunisia: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Bratus E, Yuvko O, Pertseva T, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Nizamuddin S, Morrissey I, Manenzhe R, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

TORUMKUNEY D, Canton R, Pitart C, Sanguinetti M, et al
Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

MIN P, Yao J, Ruan S, Zhou L, et al
Global phylogeography and genomic characterization of blaNDM-1-positive carbapenem-resistant Acinetobacter soli.
J Antimicrob Chemother. 2025 Nov 24:dkaf437. doi: 10.1093.
PubMed Abstract available

JOHNSON A, Madec JY, Pournaras S
JAC Supplement: Survey of Antibiotic Resistance (SOAR) results 4-respiratory pathogen susceptibility.
J Antimicrob Chemother. 2025;80.
PubMed

BENSACI MF, Bauer KA, Klinker K, Cota J, et al
Post-pandemic trends in Streptococcus pneumoniae serotype epidemiology and antibiotic susceptibility in adults with invasive and non-invasive pneumococcal disease in the USA (2022-2023).
J Antimicrob Chemother. 2025 Nov 20:dkaf414. doi: 10.1093.
PubMed Abstract available

ALMEIDA-SANTOS AC, Tedim AP, Duarte B, Silva LM, et al
Unnoticed spread of linear VanA-plasmids in vancomycin-variable Enterococcus faecium strains across different regions: a diagnostics challenge.
J Antimicrob Chemother. 2025 Nov 20:dkaf409. doi: 10.1093.
PubMed Abstract available

MANSOURI A, Durazzi F, Ihsan MA, Griffin S, et al
Identification of antimicrobial resistance genes in Escherichia coli through network diffusion.
J Antimicrob Chemother. 2025 Nov 11:dkaf404. doi: 10.1093.
PubMed Abstract available

LU R, Li X, Yang W, Chen J, et al
In vitro activity of contezolid and other comparators against clinical Staphylococcus and Enterococcus: a multicenter study in China.
J Antimicrob Chemother. 2025;80:3011-3020.
PubMed Abstract available

DJIYOU ABD, Penda CI, Madec Y, Ngondi GD, et al
High level of archived and circulating HIV-1 drug resistance mutations in adolescents with a detectable viremia in Cameroon.
J Antimicrob Chemother. 2025;80:3160-3164.
PubMed Abstract available

TOEPFER S, Lamping E, James JE, Zenz LM, et al
Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus.
J Antimicrob Chemother. 2025;80:3065-3078.
PubMed Abstract available

GILBERT M, Ferre VM, Guilbaud R, Digumber M, et al
How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy?
J Antimicrob Chemother. 2025;80:3133-3138.
PubMed Abstract available

ARMENIA D, Marchegiani G, Spagnuolo V, Bellocchi MC, et al
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.
J Antimicrob Chemother. 2025;80:3101-3106.
PubMed Abstract available

TOYTING-HIRAISHI J, Sato T, Tohyama M, Fujino T, et al
Potential human health risk of carbapenem-non-susceptible Pseudomonas aeruginosa from companion animals.
J Antimicrob Chemother. 2025;80:3043-3056.
PubMed Abstract available

GRAFIA I, Moll-Febrer A, Santillan SJ, Rodrigo C, et al
Multidrug resistance and recurrence in urinary bacteraemia among cancer patients.
J Antimicrob Chemother. 2025;80:3026-3033.
PubMed Abstract available

CHUA TP, Huaman JL, Danielewski J, Bradshaw CS, et al
In vitro evolution provides insights into mechanisms of Mycoplasma genitalium resistance to moxifloxacin.
J Antimicrob Chemother. 2025;80:2970-2977.
PubMed Abstract available

JIANG X, Cao D, Qiu Y, Dong X, et al
Novel mutations associated with clofazimine resistance in Mycobacterium intracellulare.
J Antimicrob Chemother. 2025;80:2954-2957.
PubMed Abstract available

BOYD SE, Wootton M, Howe RA, Livermore DM, et al
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.
J Antimicrob Chemother. 2025 Nov 3:dkaf392. doi: 10.1093.
PubMed Abstract available

October 2025

REYNOLDS R, Mushtaq S, Hope R, Horner C, et al
Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

REYNOLDS R, Felmingham D, Mushtaq S, Horner C, et al
Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

REYNOLDS R, Mushtaq S, Hope R, Horner C, et al
Antimicrobial resistance among Gram-positive agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

REYNOLDS R, Morrissey I, Mushtaq S, Horner C, et al
Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

HORNER C, Reynolds R, Mushtaq S, Chaudhry A, et al
Trends of serotypes and resistance among Streptococcus pneumoniae in the UK and Ireland (1999-2019).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

MACGOWAN AP, Reynolds R, Parcell BJ, Livermore DM, et al
Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

PARCELL BJ, Horner C, Reynolds R, Allen M, et al
Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

ALLEN M, Reynolds R, Mushtaq S, Nsonwu O, et al
The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: methods and limitations.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

CHOWDHURY FR, Findlay BL
Sequential antibiotic exposure restores antibiotic susceptibility.
J Antimicrob Chemother. 2025 Oct 8:dkaf350. doi: 10.1093.
PubMed Abstract available

LAI CC, Liu CY, Huang KJ, Huang YT, et al
Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
PubMed Abstract available

HSU CH, Li C, Harrison L, Zhao S, et al
Genomic structure of class 1 and 2 integrons in non-typhoidal Salmonella isolated from food animals and related meat products in the USA.
J Antimicrob Chemother. 2025;80:2844-2853.
PubMed Abstract available

YANG J, Jiang T, Zhang M, Xue J, et al
Phenotypic and genotypic profiles of clinical isolates of various Nocardia species to carbapenems and fluoroquinolones.
J Antimicrob Chemother. 2025;80:2862-2872.
PubMed Abstract available

LARKIN C, Valappil SP, Palanisamy N
Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis.
J Antimicrob Chemother. 2025;80:2609-2621.
PubMed Abstract available

HALIM J, Keane AP, Bouzo J, Aderibigbe T, et al
Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant Acinetobacter baumannii patient isolates with diverse resistance mechanisms.
J Antimicrob Chemother. 2025;80:2814-2824.
PubMed Abstract available

ZAGHI I, Cricca M, Roberts JA, Brandolini M, et al
Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria.
J Antimicrob Chemother. 2025;80:2705-2713.
PubMed Abstract available

SKOVMAND S, Norgaard C, Salado-Rasmussen K, Jensen JS, et al
In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium.
J Antimicrob Chemother. 2025;80:2676-2681.
PubMed Abstract available

September 2025

CINCOTTA SE, Ostrowsky BE, Howard-Anderson J, Beekmann SE, et al
Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections.
J Antimicrob Chemother. 2025 Sep 30:dkaf371. doi: 10.1093.
PubMed Abstract available

IACHKINE J, Alexandre K, Marlat C, Briant A, et al
Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
PubMed Abstract available

GIARRATANA LR, Pirolo M, Roch FF, Conrady B, et al
Evolving landscape of methicillin-resistant Staphylococcus pseudintermedius: the emergence of new epidemic waves across Europe, Asia and North America.
J Antimicrob Chemother. 2025 Sep 27:dkaf340. doi: 10.1093.
PubMed Abstract available

WITKOWSKA A, Biedrzycka M, Izdebski R, Literacka E, et al
Assessment of an LC coupled with tandem MS (LC-MS/MS) tool in the detection of antimicrobial resistance mechanisms in Enterobacterales.
J Antimicrob Chemother. 2025 Sep 24:dkaf339. doi: 10.1093.
PubMed Abstract available

XU W, Yan P, Li Y, Sun B, et al
The toxin-antitoxin system SavRS contributes to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus by mediating cell wall thickening.
J Antimicrob Chemother. 2025 Sep 23:dkaf325. doi: 10.1093.
PubMed Abstract available

ELADAWY M, Heslop N, Negus D, Thomas JC, et al
Phenotype-genotype discordance in antimicrobial resistance profiles of Gram-negative uropathogens recovered from catheter-associated urinary tract infections in Egypt.
J Antimicrob Chemother. 2025 Sep 23:dkaf352. doi: 10.1093.
PubMed Abstract available

ZHU Y, Du S, Schwarz S, Hou J, et al
Co-existence of the oxazolidinone resistance genes cfr and optrA on a novel multiresistance plasmid from a methicillin-resistant Macrococcoides bohemicum strain.
J Antimicrob Chemother. 2025 Sep 22:dkaf333. doi: 10.1093.
PubMed Abstract available

YANG P, Liu C, Zheng J, Yi J, et al
Rapid replacement of blaKPC variant in ST11 carbapenem-resistant and hypervirulent Klebsiella pneumoniae contributed to ceftazidime/avibactam resistance during severe in vivo infection.
J Antimicrob Chemother. 2025 Sep 18:dkaf337. doi: 10.1093.
PubMed Abstract available

PAPAIOANNU BORJESSON R, Diotallevi S, Lolatto R, Cenderello G, et al
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.
J Antimicrob Chemother. 2025;80:2369-2374.
PubMed Abstract available

POCIUPANY M, Gillemot S, Georgala A, Snoeck R, et al
Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient.
J Antimicrob Chemother. 2025;80:2474-2483.
PubMed Abstract available

NAIR S, Barker CR, Patel V, Poh CY, et al
Highly drug-resistant Vibrio cholerae harbouring blaPER-7 isolated from travellers returning to England.
J Antimicrob Chemother. 2025;80:2428-2432.
PubMed Abstract available

LIU J, Yang X, Deng X, Hou M, et al
Transmitted drug resistance profiles among people living with HIV-1 in Henan province, China, 2024.
J Antimicrob Chemother. 2025;80:2496-2502.
PubMed Abstract available

IMOLI D, Maingi JM, Mbae C, Kavai SM, et al
Genomic characterization of multidrug-resistant extended-spectrum beta-lactamase-producing Vibrio cholerae O1 strains from 2022 cholera outbreak in Kenya.
J Antimicrob Chemother. 2025;80:2399-2407.
PubMed Abstract available

August 2025

HAO J, Lu F, Chen P, Ji C, et al
Characterization of blaOXA-542-mediated carbapenem resistance in Acinetobacter baumannii.
J Antimicrob Chemother. 2025 Aug 29:dkaf311. doi: 10.1093.
PubMed Abstract available

LI J, Hou W, Chang J, Tian X, et al
The pivotal role of acnA in linking carbon metabolism to virulence and antimicrobial resistance in methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 2025 Aug 28:dkaf317. doi: 10.1093.
PubMed Abstract available

MCCRACKEN M, Walkty A, Adam HJ, Baxter M, et al
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

MATASEJE LF, Lerminiaux N, Lagace-Wiens P, Walkty A, et al
Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

ADAM HJ, Golden AR, Martin I, Baxter MR, et al
Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

BRAHAMI A, Karlowsky JA, McCracken M, Golding GR, et al
Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

ZHANEL GG, Baxter MR, Lagace-Wiens P, Walkty A, et al
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

ZHANEL GG, Baxter MR, Golden AR, Lagace-Wiens P, et al
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

LAGACE-WIENS P, Mataseje L, McCracken M, Walkty A, et al
Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

HURLEY JC, Madec JY
The CANWARD studies: Canadian Antimicrobial Resistance Alliance (CARA) Canadian Hospital Ward Antibiotic Resistance Surveillance collection.
J Antimicrob Chemother. 2025;80.
PubMed

SUN Y, McGiffin D, Ye L, Kostoulias X, et al
Low bacterial metabolism as a central mechanism of antimicrobial resistance and potential therapeutic target of staphylococcal biofilms in ventricular assist device driveline infections.
J Antimicrob Chemother. 2025 Aug 26:dkaf316. doi: 10.1093.
PubMed Abstract available

CERCENADO E, Marin M, Iglesias M, Jimenez L, et al
Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin.
J Antimicrob Chemother. 2025 Aug 21:dkaf308. doi: 10.1093.
PubMed Abstract available

MANCINI S, Seth-Smith HMB, Kolesnik-Goldmann N, Mermod M, et al
Performance of disc diffusion and gradient strip test on different Mueller-Hinton agar media plates and ComASP(R) and Bruker UMIC(R) Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa
J Antimicrob Chemother. 2025 Aug 18:dkaf301. doi: 10.1093.
PubMed Abstract available

ZENG Q, Huang H, Lu J, Wu L, et al
Comparative outcomes of polymyxins in neurocritical care patients with carbapenem-resistant Gram-negative bacterial pneumonia: a retrospective cohort study.
J Antimicrob Chemother. 2025 Aug 7:dkaf295. doi: 10.1093.
PubMed Abstract available

BALAKUNTLA J, Simjee S, Mane SP, Tice G, et al
Distinct population structure and genomic context of NarAB between broiler and human clinical Enterococcus isolates.
J Antimicrob Chemother. 2025 Aug 7:dkaf296. doi: 10.1093.
PubMed Abstract available

ANASTASSOPOULOU C, Panagiotopoulos AP, Ferous S, Tsakris A, et al
Phages connect the biological dots of antimicrobial resistance: from genesis and spread to alternative treatment modules.
J Antimicrob Chemother. 2025 Aug 6:dkaf293. doi: 10.1093.
PubMed Abstract available

GAGLIARDINI R, De Benedittis S, Tavelli A, Lapadula G, et al
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.
J Antimicrob Chemother. 2025;80:2169-2178.
PubMed Abstract available

BRENCIANI A, Massacci FR, Albini E, Cucco L, et al
Novel integrative and conjugative elements carrying cfr(B) and cfr(C) linezolid resistance genes in Clostridioides difficile isolates from calves, Italy.
J Antimicrob Chemother. 2025;80:2280-2284.
PubMed Abstract available

SADER HS, Kimbrough JH, Winkler ML, Castanheira M, et al
Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023).
J Antimicrob Chemother. 2025;80:2070-2079.
PubMed Abstract available

WATERA C, Da Silva JF, Namayanja G, Asio JN, et al
HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022.
J Antimicrob Chemother. 2025;80:2126-2134.
PubMed Abstract available

July 2025

FERRANDO ML, Saluzzo F, Frederiksen RF, Slettemeas JS, et al
Determination of epidemiological cut-off values for Narasin, Salinomycin, Lasalocid and Monensin in Enterococcus faecium.
J Antimicrob Chemother. 2025 Jul 31:dkaf113. doi: 10.1093.
PubMed Abstract available

ABEGAZ FA, Al-Mir H, Kostyanev T, Prifti K, et al
Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up.
J Antimicrob Chemother. 2025 Jul 29:dkaf266. doi: 10.1093.
PubMed Abstract available

CHEN X, Ouyang F, Wang N, Liu D, et al
Synergistic effects of DHA27 combined with gentamicin against methicillin-resistant Staphylococcus aureus in vitro and in vivo.
J Antimicrob Chemother. 2025 Jul 25:dkaf239. doi: 10.1093.
PubMed Abstract available

NODA M, Furuta A, Yashima S, Yaguchi D, et al
Fluctuations in copy number of the class A carbapenemase gene blaFRI appear to confer high-level carbapenem resistance.
J Antimicrob Chemother. 2025 Jul 25:dkaf258. doi: 10.1093.
PubMed Abstract available

DEL MONTE M, Kaleci S, Chester J, Zerbato V, et al
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.
J Antimicrob Chemother. 2025 Jul 22:dkaf242. doi: 10.1093.
PubMed Abstract available

OU TH, Yang JL, Lin CY, Huang SH, et al
Impact of empiric anti-VRE therapy on survival in vancomycin-resistant enterococcal bloodstream infection.
J Antimicrob Chemother. 2025 Jul 17:dkaf225. doi: 10.1093.
PubMed Abstract available

SINGH S, Adhikari S, Varshney N, Rani C, et al
Overcoming antimicrobial resistance in Helicobacter pylori: the roles of collateral sensitivity and biofilm dynamics.
J Antimicrob Chemother. 2025 Jul 15:dkaf233. doi: 10.1093.
PubMed Abstract available

MORAN RA, Hall RM
The catA1 chloramphenicol resistance gene originated in Atlantibacter hermannii.
J Antimicrob Chemother. 2025 Jul 11:dkaf227. doi: 10.1093.
PubMed

VAN DEN BIGGELAAR RHGA, Erdkamp D, de Visser AW, van den Eeden SJF, et al
Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 2025 Jul 1:dkaf198. doi: 10.1093.
PubMed Abstract available

CHUA TP, Danielewski J, Bradshaw CS, Machalek DA, et al
A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro.
J Antimicrob Chemother. 2025;80:2044-2050.
PubMed Abstract available

PARANOS P, Siopi M, Papanikolaou E, Vourli S, et al
Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations.
J Antimicrob Chemother. 2025;80:1997-2006.
PubMed Abstract available

LUO Z, Ning Y, Xiao M, Guo D, et al
High azole non-wild type rates and nosocomial microsatellite typing aggregation of Wickerhamomyces anomalus in China according to a 12-year multicenter surveillance study.
J Antimicrob Chemother. 2025;80:1964-1971.
PubMed Abstract available

ZHAN Z, Cui Y, He S, Chang J, et al
Molecular characteristics of chromosome-mediated colistin resistance in foodborne Salmonella isolates in China.
J Antimicrob Chemother. 2025;80:1951-1963.
PubMed Abstract available

KOONG J, Hall RM, Hamidian M
Genomic characteristics of the multiresistant Acinetobacter baumannii global clone 1 reference strain A297/RUH875.
J Antimicrob Chemother. 2025;80:1988-1992.
PubMed Abstract available

ATTWOOD MLG, Noel A, Griffin P, Racine E, et al
In vitro activity of NOSO-502, a novel-action antimicrobial, against clinical strains of Enterobacterales including MDR strains.
J Antimicrob Chemother. 2025;80:1942-1946.
PubMed Abstract available

DAVIDSON HC, Yau T, Dunstan I, Houston A, et al
Early use of the novel antifungal rezafungin: a case series and literature review.
J Antimicrob Chemother. 2025;80:1885-1892.
PubMed Abstract available

June 2025

LI J, He J, Huang Q
Comment on: Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.
J Antimicrob Chemother. 2025 Jun 27:dkaf200. doi: 10.1093.
PubMed

QIU X, Tang J, Zhou J, Zhao X, et al
Novel tmexC7D2-toprJ5 gene cluster and transposon Tn7759 carrying blaVIM-2 and blaOXA-10 genes in a carbapenem-resistant Pseudomonas putida from urban sewage.
J Antimicrob Chemother. 2025 Jun 25:dkaf203. doi: 10.1093.
PubMed

AVCU G
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a Tertiary University Hospital-right to reply-author's response.
J Antimicrob Chemother. 2025 Jun 25:dkaf201. doi: 10.1093.
PubMed

HONDA T, Vazquez-Montes MDLA, Fanshawe TR, Stoesser N, et al
The impact of inter-infection time on antimicrobial resistance profiles in women with multiple urinary tract infections over time.
J Antimicrob Chemother. 2025 Jun 24:dkaf194. doi: 10.1093.
PubMed Abstract available

RASMUSSEN A, Hammerum AM, Hansen F, Soes LM, et al
Carbapenem resistance in Escherichia marmotae: characterization of IncL plasmids carrying blaOXA-48.
J Antimicrob Chemother. 2025 Jun 16:dkaf188. doi: 10.1093.
PubMed

ZHENG YD, Xu J, Wu J, Zhong T, et al
Oleanolic acid derivative bardoxolone combats multidrug-resistant Staphylococcus aureus by destroying cell membrane and pyruvate metabolism pathway.
J Antimicrob Chemother. 2025 Jun 10:dkaf190. doi: 10.1093.
PubMed Abstract available

KIHLBERG P, Bech Johannesen T, Stegger M, Cajander S, et al
Reliability of disc diffusion testing and molecular epidemiology of penicillin-susceptible Staphylococcus aureus bacteraemia.
J Antimicrob Chemother. 2025 Jun 10:dkaf187. doi: 10.1093.
PubMed Abstract available

EL NAGAR A, Dewe TCM, Broadfoot F, Teale C, et al
Decreasing antimicrobial resistance in representative UK livestock species was associated with reduced total sales of antimicrobials in the last decade.
J Antimicrob Chemother. 2025 Jun 5:dkaf145. doi: 10.1093.
PubMed Abstract available

EDSLEV SM, Laurent F, Mansson E, Johannesen TB, et al
Antibiotic resistance and population structure of Staphylococcus epidermidis from prosthetic joint infections in Sweden and France.
J Antimicrob Chemother. 2025 Jun 3:dkaf166. doi: 10.1093.
PubMed Abstract available

RUGEMALILA J, Ndege R, Kunambi P, Shabani S, et al
Viral suppression after failure of PI-based ART among adolescents and youths with and without drug resistance mutations: a longitudinal analysis in Tanzania.
J Antimicrob Chemother. 2025;80:1694-1701.
PubMed Abstract available

HANDAL N, Kaspersen H, Mo SS, Cabanel N, et al
A comparative study of the molecular characteristics of human uropathogenic Escherichia coli collected from two hospitals in Norway and France in 2019.
J Antimicrob Chemother. 2025;80:1707-1715.
PubMed Abstract available

ZHANG BL, Li H, Wang WX, Chen XZ, et al
Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model.
J Antimicrob Chemother. 2025;80:1613-1625.
PubMed Abstract available

HAMZE H, Payne M, Stefanovic A, Lowe CF, et al
Helicobacter pylori culture positivity and antimicrobial susceptibility profiles (Vancouver, Canada).
J Antimicrob Chemother. 2025;80:1640-1646.
PubMed Abstract available

RIPAMONTI D, Comi L, Francavilla A, Valenti D, et al
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study).
J Antimicrob Chemother. 2025;80:1665-1672.
PubMed Abstract available

LIN D, Zhang Y, Luo Z, Wang J, et al
Unravelling the genetic contributors to linezolid resistance in Mycobacterium smegmatis: insights from a transposon library.
J Antimicrob Chemother. 2025;80:1595-1603.
PubMed Abstract available

SARIA P, Doulidis PG, Desvars-Larrive A, Toth AG, et al
Pandemic human-associated extended-spectrum beta-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs.
J Antimicrob Chemother. 2025;80:1573-1576.
PubMed Abstract available

May 2025

CHO H, Park KT
A novel methicillin-resistant Staphylococcus aureus lineage (ST4174) with an uncharacterized SCCmec variant identified in Korean pigs.
J Antimicrob Chemother. 2025 May 31:dkaf178. doi: 10.1093.
PubMed

CANAS MA, Garcia-de-la-Maria C, Garcia-Gonzalez J, Jimenez MP, et al
Efficacy of linezolid in monotherapy q12h versus q8h versus combined with daptomycin in the treatment of experimental endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus strains.
J Antimicrob Chemother. 2025 May 27:dkaf149. doi: 10.1093.
PubMed Abstract available

KRISHNAPRASAD VH, Nayak V, Kumar S
World Health Organisation's Bacterial Pathogen Priority List (BPPL) 2017 and BPPL 2024 to combat global antimicrobial resistance crisis: 'challenges and opportunities'.
J Antimicrob Chemother. 2025 May 27:dkaf167. doi: 10.1093.
PubMed Abstract available

HTAIK K, Vodstrcil LA, Plummer EL, Matthews LG, et al
Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium.
J Antimicrob Chemother. 2025 May 22:dkaf142. doi: 10.1093.
PubMed Abstract available

BUTSCHEID Y, Frey PM, Pfister M, Pagani L, et al
Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study.
J Antimicrob Chemother. 2025 May 14:dkaf136. doi: 10.1093.
PubMed Abstract available

VERA-YUNCA D, Matias C, Vingsbo Lundberg C, Friberg LE, et al
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.
J Antimicrob Chemother. 2025 May 9:dkaf140. doi: 10.1093.
PubMed Abstract available

SINGH R, Mukherjee S, Harrision LB, McDermott PF, et al
Cross-resistance to 14-, 15- and 16-membered ring macrolides in Salmonella and Campylobacter.
J Antimicrob Chemother. 2025;80:1445-1452.
PubMed Abstract available

April 2025

LOCKE JB, Andes D, Flanagan S, Redell M, et al
Activity of rezafungin against Candida auris.
J Antimicrob Chemother. 2025 Apr 30:dkaf124. doi: 10.1093.
PubMed Abstract available

FIFER H, Johnson A
The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment.
J Antimicrob Chemother. 2025 Apr 10:dkaf109. doi: 10.1093.
PubMed Abstract available

ORTONNE V, Bouvier-Alias M, Vo-Quang E, Cappy P, et al
Performance evaluation of a fully automated deep sequencing platform for hepatitis B genotyping and resistance testing.
J Antimicrob Chemother. 2025;80:919-926.
PubMed Abstract available

KOSTYANEV T, Al-Mir H, Prifti K, Rasmussen LB, et al
External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.
J Antimicrob Chemother. 2025;80:1037-1046.
PubMed Abstract available

JAKUBU V, Cechova M, Musilek M, Malisova L, et al
Amino acid substitutions in PBP3 in Haemophilus influenzae strains, their phenotypic detection and impact on resistance to beta-lactams.
J Antimicrob Chemother. 2025;80:980-987.
PubMed Abstract available

OMODING D, Musinguzi N, Boum Y 2nd, Muzoora C, et al
Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda.
J Antimicrob Chemother. 2025;80:955-961.
PubMed Abstract available

REBELO AR, Bortolaia V, Leekitcharoenphon P, Hansen DS, et al
One day in Denmark: whole-genome sequence-based analysis of Escherichia coli isolates from clinical settings.
J Antimicrob Chemother. 2025;80:1011-1021.
PubMed Abstract available

ZHENG YQ, Li QG, Latge JP, Tang XK, et al
Potential risk of cross-resistance to voriconazole in HIV/AIDS patients with Talaromyces marneffei infection and the mechanisms of the cross-resistance.
J Antimicrob Chemother. 2025;80:976-979.
PubMed Abstract available

ALIDJINOU EK, Coulon P, Tetart M, Guigon A, et al
Defective HIV-1 DNA pol sequences are not associated with HIV-1 DNA levels and drive most APOBEC-context drug resistance mutations.
J Antimicrob Chemother. 2025;80:941-946.
PubMed Abstract available

D'ANTONI ML, Falkard B, Andreatta K, Cox S, et al
Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir.
J Antimicrob Chemother. 2025;80:962-966.
PubMed Abstract available

SHU Y, Liu J, Yang C, Li J, et al
Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study.
J Antimicrob Chemother. 2025;80:947-954.
PubMed Abstract available

March 2025

MANCINI S, Greiner M, Egli A, Nolte O, et al
In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin.
J Antimicrob Chemother. 2025 Mar 18:dkaf084. doi: 10.1093.
PubMed

SCHRODER D, Cherdtrakulkiat T, Doanh LH, Golparian D, et al
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gono
J Antimicrob Chemother. 2025 Mar 18:dkaf066. doi: 10.1093.
PubMed Abstract available

CINTHI M, Coccitto SN, Simoni S, Gherardi G, et al
The optrA, cfr(D) and vanA genes are co-located on linear plasmids in linezolid- and vancomycin-resistant enterococcal clinical isolates in Italy.
J Antimicrob Chemother. 2025 Mar 17:dkaf082. doi: 10.1093.
PubMed Abstract available

PAGANO L, Fernandez OM
Clinical aspects and recent advances in fungal diseases impacting human health.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

ARENDRUP MC, Cordonnier C
Refractory versus resistant invasive aspergillosis.
J Antimicrob Chemother. 2025;80.
PubMed Abstract available

WU S, Zhang L, Luo X, Lin C, et al
In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis.
J Antimicrob Chemother. 2025 Mar 13:dkaf064. doi: 10.1093.
PubMed Abstract available

LIU Q, Zhou X, Du Z, Wang X, et al
Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report.
J Antimicrob Chemother. 2025 Mar 11:dkaf069. doi: 10.1093.
PubMed

BRAND C, Newton-Foot M, Grobbelaar M, Whitelaw A, et al
Antibiotic-induced stress responses in Gram-negative bacteria and their role in antibiotic resistance.
J Antimicrob Chemother. 2025 Mar 7:dkaf068. doi: 10.1093.
PubMed Abstract available

DING J, Hameed HMA, Long L, Zhang J, et al
Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence.
J Antimicrob Chemother. 2025;80:746-751.
PubMed Abstract available

ABDI B, Saliba S, Wirden M, Faycal A, et al
No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens.
J Antimicrob Chemother. 2025;80:810-816.
PubMed Abstract available

KARADOGAN E, Sertcelik A, Dizman GT, Uzar H, et al
A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa.
J Antimicrob Chemother. 2025;80:788-796.
PubMed Abstract available

WIRDEN M, Abdi B, Lambert-Niclot S, Chaix ML, et al
Major role of dolutegravir in the emergence of the S147G integrase resistance mutation.
J Antimicrob Chemother. 2025;80:692-696.
PubMed Abstract available

CHOGA OT, Lemogang GM, Choga WT, Muzanywa G, et al
High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana.
J Antimicrob Chemother. 2025;80:767-776.
PubMed Abstract available

CLEMENTE T, Diotallevi S, Minisci D, Di Biagio A, et al
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
J Antimicrob Chemother. 2025;80:731-737.
PubMed Abstract available

FAROOQ A, Martens M, Kroemer N, Pfaffendorf C, et al
Pharmacokinetic/pharmacodynamic analysis of meropenem and fosfomycin combinations in in vitro time-kill and hollow-fibre infection models against multidrug-resistant and carbapenemase-producing Klebsiella pneumoniae.
J Antimicrob Chemother. 2025;80:701-712.
PubMed Abstract available

SOULIE C, Agher R, Fauchois A, Abdi B, et al
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs.
J Antimicrob Chemother. 2025;80:697-700.
PubMed Abstract available

TOBIN LA, Abu Sabah E, Lebreton F, Myers GSA, et al
Genomic analysis of early ST32 Acinetobacter baumannii strains recovered in US military treatment facilities reveals distinct lineages and links to the origins of the Tn6168 ampC transposon.
J Antimicrob Chemother. 2025;80:666-675.
PubMed Abstract available

MUSHTAQ S, Vickers A, Doumith M, Garello P, et al
Frequencies and mechanisms of mutational resistance to ceftibuten/avibactam in Enterobacterales.
J Antimicrob Chemother. 2025;80:645-656.
PubMed Abstract available

February 2025

SERAPIDE F, Serraino R, Spadafora L, Bernardi M, et al
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience.
J Antimicrob Chemother. 2025 Feb 25:dkaf055. doi: 10.1093.
PubMed Abstract available

LODHIA Z, Costa Da Silva J, Correia C, Cordeiro D, et al
Surveying genetic markers of antibiotic resistance and genomic background in Chlamydia trachomatis: insights from a multiplex NGS-based approach in clinical strains from Portugal.
J Antimicrob Chemother. 2025 Feb 17:dkaf036. doi: 10.1093.
PubMed Abstract available

WERTH BJ, Zhang R, Barreras Beltran IA, Penewit K, et al
Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effect with other antimicrobials.
J Antimicrob Chemother. 2025 Feb 12:dkaf042. doi: 10.1093.
PubMed Abstract available

EDSLEV SM, Aarris M, Nielsen KL, Hertz FB, et al
rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis.
J Antimicrob Chemother. 2025 Feb 6:dkaf035. doi: 10.1093.
PubMed Abstract available

XING H, Zhang L, Li C, Schwarz S, et al
Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate.
J Antimicrob Chemother. 2025 Feb 6:dkaf034. doi: 10.1093.
PubMed Abstract available

BIANCO G, Boattini M, Lupo L, Ambretti S, et al
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study
J Antimicrob Chemother. 2025;80:583-592.
PubMed Abstract available

JO J, Kim SJ, Kwon KT, Ko KS, et al
Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii.
J Antimicrob Chemother. 2025;80:496-502.
PubMed Abstract available

CUI XD, Liu SB, Wang RY, He DD, et al
Investigation on the reversal effect of closantel on colistin resistance in MCR-1 positive Escherichia coli based on dose-response relationship.
J Antimicrob Chemother. 2025;80:528-537.
PubMed Abstract available

PAPAIOANNU BORJESSON R, Clemente T, Diotallevi S, Lolatto R, et al
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.
J Antimicrob Chemother. 2025;80:405-408.
PubMed Abstract available

TUMBARELLO M, Giuliano G, Criscuolo M, Del Principe MI, et al
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study.
J Antimicrob Chemother. 2025;80:386-398.
PubMed Abstract available

January 2025

BITTERMAN R, Awwad A, Darawsha B, Dallashi H, et al
Ceftaroline versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia, a matched cohort study.
J Antimicrob Chemother. 2025 Jan 28:dkaf009. doi: 10.1093.
PubMed Abstract available

CADDEY B, Shaukat W, Tang KL, Barkema HW, et al
Vancomycin-resistant Enterococcus prevalence and its association along the food chain: a systematic review and meta-analysis.
J Antimicrob Chemother. 2025 Jan 24:dkaf008. doi: 10.1093.
PubMed Abstract available

Correction to: Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
J Antimicrob Chemother. 2025 Jan 17:dkaf021. doi: 10.1093.
PubMed

OHEMU GP, Read C, Onwukwe CD, Olorunleke SO, et al
Educate, Advocate, Act Now: a sustainable approach to combating antimicrobial resistance TODAY.
J Antimicrob Chemother. 2025 Jan 7:dkae478. doi: 10.1093.
PubMed Abstract available

MOREY F, Giron-Callejas A, Manzanero R, Urbina A, et al
Pretreatment and acquired HIV drug resistance in Belize-results of nationally representative surveys, 2021-22.
J Antimicrob Chemother. 2025;80:292-300.
PubMed Abstract available

MELLO TP, Ramos LS, Andrade VV, Torres-Santos EC, et al
Elucidating the augmented resistance profile of Scedosporium/Lomentospora species to azoles in a cystic fibrosis mimic environment.
J Antimicrob Chemother. 2025;80:106-115.
PubMed Abstract available

YANXIA S, Xuewei W, Gang L, Wei J, et al
Analysis on characteristics and multilocus sequence typing of Clostridium perfringens in western China.
J Antimicrob Chemother. 2025;80:216-226.
PubMed Abstract available

CHEN S, Shang Y, Zheng J, Huo F, et al
In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis.
J Antimicrob Chemother. 2025;80:262-269.
PubMed Abstract available

BALTAS I, Patel T, Soares AL
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
J Antimicrob Chemother. 2025;80:59-67.
PubMed Abstract available

HIRABAYASHI A, Yano H, Yahara K, Aoki S, et al
Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan.
J Antimicrob Chemother. 2025;80:192-199.
PubMed Abstract available

ANDO N, Mizushima D, Takano M, Mitobe M, et al
Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.
J Antimicrob Chemother. 2025;80:247-253.
PubMed Abstract available

ROBERTSON A, Coutinho G, Mantzourani E, Szomolay B, et al
Over-the-counter antibiotics compromising aminoglycoside activity.
J Antimicrob Chemother. 2025;80:87-94.
PubMed Abstract available

PARIONA JGM, Vasquez-Ponce F, Pariona EMM, Sousa-Carmo RR, et al
Efficacy of meropenem against ceftazidime-avibactam-resistant Klebsiella pneumoniae producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114.
J Antimicrob Chemother. 2025;80:162-168.
PubMed Abstract available

MARCELIN AG, Soulie C, Wirden M, Barriere G, et al
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.
J Antimicrob Chemother. 2025;80:95-101.
PubMed Abstract available

December 2024

KIM SH, Kim HM, Chung DR, Ko JH, et al
Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
J Antimicrob Chemother. 2024 Dec 31:dkae466. doi: 10.1093.
PubMed Abstract available

ERSOY SC, Madrigal SL, Proctor RA, Chambers HF, et al
NaHCO3 modulates the bla operon and beta-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA).
J Antimicrob Chemother. 2024 Dec 20:dkae455. doi: 10.1093.
PubMed Abstract available

HANAI Y, Matsumoto K, Endo A, Hanawa K, et al
Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study.
J Antimicrob Chemother. 2024 Dec 17:dkae442. doi: 10.1093.
PubMed Abstract available

ASSEFA GM, Roberts JA, Aslan AT, Mohammed SA, et al
A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria.
J Antimicrob Chemother. 2024 Dec 17:dkae451. doi: 10.1093.
PubMed Abstract available

DOELMAN TA, Adriaens N, Westerhuis BM, Bruisten SM, et al
Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations.
J Antimicrob Chemother. 2024 Dec 4:dkae430. doi: 10.1093.
PubMed Abstract available

FIFER H, Doumith M, Rubinstein L, Mitchell L, et al
Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.
J Antimicrob Chemother. 2024;79:3332-3339.
PubMed Abstract available

STERN A, Henig I, Cohen M, Gur I, et al
Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study.
J Antimicrob Chemother. 2024;79:3289-3296.
PubMed Abstract available

HUANG Y, Liao M, Hu X, Hu H, et al
Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins.
J Antimicrob Chemother. 2024;79:3210-3229.
PubMed Abstract available

ALVAREZ C, Nastro M, Goyheneche B, Potente N, et al
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina.
J Antimicrob Chemother. 2024;79:3174-3177.
PubMed Abstract available

November 2024

LEROY AG, Lemenand O, Thibaut S, Coeffic T, et al
Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home-acquired urinary tract infections.
J Antimicrob Chemother. 2024 Nov 29:dkae431. doi: 10.1093.
PubMed Abstract available

LIU Q, Li S, Wang X, Lin Y, et al
Comparative evaluation of eravacycline susceptibility testing methods in 587 clinical carbapenem-resistant Acinetobacter baumannii isolates: broth microdilution, MIC test strip and disc diffusion.
J Antimicrob Chemother. 2024 Nov 21:dkae426. doi: 10.1093.
PubMed Abstract available

MCGUIRE E, Ready D, Ellaby N, Potterill I, et al
A case of penicillin-resistant group B Streptococcus isolated from a patient in the UK.
J Antimicrob Chemother. 2024 Nov 15:dkae419. doi: 10.1093.
PubMed Abstract available

QIAN C, Hu P, Guo W, Han Y, et al
Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.
J Antimicrob Chemother. 2024;79:2965-2974.
PubMed Abstract available

LODISE TP, Obi EN, Watanabe AH, Yucel E, et al
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa.
J Antimicrob Chemother. 2024;79:2954-2964.
PubMed Abstract available

PARK J, Lee D, Yi H, Yun CW, et al
Bacterial persistence to antibiotics activated by tRNA mutations.
J Antimicrob Chemother. 2024;79:2923-2931.
PubMed Abstract available

YANG F, Sun X, Fu Y, Zhao F, et al
High-level ceftriaxone resistance due to transfer of penA allele 60.001 into endemic gonococcal lineages in Hangzhou, China.
J Antimicrob Chemother. 2024;79:2854-2857.
PubMed Abstract available

October 2024

AVCU G, Erci E, Bilen NM, Ersayoglu I, et al
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.
J Antimicrob Chemother. 2024 Oct 30:dkae387. doi: 10.1093.
PubMed Abstract available

STURARO MC, de Souza GHA, Damaceno NDS, Silva ON, et al
Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae.
J Antimicrob Chemother. 2024 Oct 25:dkae382. doi: 10.1093.
PubMed Abstract available

GHAHRAMANI A, Naghadian Moghaddam MM, Kianparsa J, Ahmadi MH, et al
Overall status of carbapenem resistance among clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis.
J Antimicrob Chemother. 2024 Oct 11:dkae358. doi: 10.1093.
PubMed Abstract available

YU L, Han X, Zhang W, Fu Y, et al
The two-component sensor factor envZ influences antibiotic resistance and virulence in the evolutionary dynamics of multidrug-resistant Salmonella enteritidis causing multisite invasive infections.
J Antimicrob Chemother. 2024 Oct 4:dkae355. doi: 10.1093.
PubMed Abstract available

SIMJEE S, Weese JS, Singh R, Trott DJ, et al
Redefining cross-resistance, co-resistance and co-selection: beyond confusion?
J Antimicrob Chemother. 2024;79:2417-2420.
PubMed Abstract available

ALIEVA KN, Golikova MV, Zinner SH
Role of volume and inoculum in MIC assessment: a study with meropenem and Klebsiella pneumoniae.
J Antimicrob Chemother. 2024;79:2698-2707.
PubMed Abstract available

HALLIDAY CL, Tay E, Green W, Law D, et al
In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020-2023.
J Antimicrob Chemother. 2024;79:2611-2621.
PubMed Abstract available

DAVIN-REGLI A, Pages JM, Vergalli J
The contribution of porins to enterobacterial drug resistance.
J Antimicrob Chemother. 2024;79:2460-2470.
PubMed Abstract available

ZHANG XW, Song JJ, Zeng SH, Huang YL, et al
Plasmid-mediated azithromycin resistance in non-typhoidal Salmonella recovered from human infections.
J Antimicrob Chemother. 2024;79:2688-2697.
PubMed Abstract available

GONZALEZ-PINTO L, Alonso-Garcia I, Blanco-Martin T, Camacho-Zamora P, et al
Impact of chromosomally encoded resistance mechanisms and transferable beta-lactamases on the activity of cefiderocol and innovative beta-lactam/beta-lactamase inhibitor combinations against Pseudomonas aeruginosa.
J Antimicrob Chemother. 2024;79:2591-2597.
PubMed Abstract available

WANG Z, Jiang H, Pang X, Li J, et al
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
J Antimicrob Chemother. 2024;79:2575-2585.
PubMed Abstract available

ESCRIHUELA-VIDAL F, Fernandez-Hidalgo N, Munoz P, Villamarin M, et al
Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort.
J Antimicrob Chemother. 2024 Oct 1:dkae345. doi: 10.1093.
PubMed Abstract available

September 2024

SHAN X, Li C, Zhang L, Zou C, et al
poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis.
J Antimicrob Chemother. 2024 Sep 27:dkae342. doi: 10.1093.
PubMed Abstract available

CORNU HEWITT B, Bossers A, van Kersen W, de Rooij MMT, et al
Associations between acquired antimicrobial resistance genes in the upper respiratory tract and livestock farm exposures: a case-control study in COPD and non-COPD individuals.
J Antimicrob Chemother. 2024 Sep 24:dkae335. doi: 10.1093.
PubMed Abstract available

YANG W, Li X, Chen J, Zhang G, et al
Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus.
J Antimicrob Chemother. 2024 Sep 24:dkae331. doi: 10.1093.
PubMed Abstract available

DRYDEN M, Corley M, Wright N, Andrewin A, et al
The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas Territories.
J Antimicrob Chemother. 2024 Sep 19:dkae330. doi: 10.1093.
PubMed Abstract available

KARLOWSKY JA, Wise MG, Hackel MA, Six DA, et al
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
J Antimicrob Chemother. 2024 Sep 17:dkae329. doi: 10.1093.
PubMed Abstract available

KRUGER-HAKER H, Kostova V, Hanke D, Kaspar H, et al
Genetic basis of macrolide resistance in porcine Pasteurella multocida isolates from the German national resistance monitoring program GERM-Vet 2008-2021.
J Antimicrob Chemother. 2024 Sep 13:dkae316. doi: 10.1093.
PubMed Abstract available

ABDELALL LM, Nagy YI, Kashef MT
Restoring vancomycin activity against resistant Enterococcus faecalis using a transcription factor decoy as a vanA operon-inhibitor.
J Antimicrob Chemother. 2024 Sep 10:dkae320. doi: 10.1093.
PubMed Abstract available

WIDERSTROM R, Aarris M, Jacobsson S, Stegger M, et al
Probing fosfomycin's potential: a study on susceptibility testing and resistance in Staphylococcus epidermidis from prosthetic joint infections.
J Antimicrob Chemother. 2024 Sep 6:dkae312. doi: 10.1093.
PubMed Abstract available

BOUTZOUKAS AE, Mackow N, Giri A, Komarow L, et al
Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections.
J Antimicrob Chemother. 2024 Sep 5:dkae306. doi: 10.1093.
PubMed Abstract available

FABENI L, Armenia D, Abbate I, Gagliardini R, et al
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
J Antimicrob Chemother. 2024;79:2152-2162.
PubMed Abstract available

ARMENIA D, Spagnuolo V, Bellocchi MC, Galli L, et al
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
J Antimicrob Chemother. 2024;79:2354-2363.
PubMed Abstract available

DAVID A, Golparian D, Jacobsson S, Stratton C, et al
In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.
J Antimicrob Chemother. 2024;79:2221-2226.
PubMed Abstract available

MAZZITELLI M, Pontillo D, Clemente T, Di Biagio A, et al
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry.
J Antimicrob Chemother. 2024;79:2163-2169.
PubMed Abstract available

GLEN KA, Lamont IL
Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to beta-lactams but inhibit cell division.
J Antimicrob Chemother. 2024;79:2170-2178.
PubMed Abstract available

DIZI ISIK A, Akkoc G, Ergenc Z, Yilmaz S, et al
The use of fosfomycin in infections caused by multidrug-resistant pathogens, especially pneumonia in children: a five-year retrospective single-centre experience.
J Antimicrob Chemother. 2024;79:2179-2185.
PubMed Abstract available

ABOUELHASSAN Y, Nicolau DP, Abdelraouf K
Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy.
J Antimicrob Chemother. 2024;79:2306-2316.
PubMed Abstract available

August 2024

PAPOUSKOVA A, Drabkova Z, Brajerova M, Krutova M, et al
The circulation of methicillin-resistant Staphylococcus aureus between humans, horses and the environment at the equine clinic.
J Antimicrob Chemother. 2024 Aug 30:dkae303. doi: 10.1093.
PubMed Abstract available

COUTO F, Martins I, Vale F, Domingues F, et al
Insights into macrolide resistance in Arcobacter butzleri: potential resistance mechanisms and impact on bacterial fitness and virulence.
J Antimicrob Chemother. 2024 Aug 19:dkae287. doi: 10.1093.
PubMed Abstract available

LUZARRAGA V, Cremniter J, Plouzeau C, Michaud A, et al
In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.
J Antimicrob Chemother. 2024 Aug 10:dkae269. doi: 10.1093.
PubMed Abstract available

Correction to: Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data.
J Antimicrob Chemother. 2024 Aug 6:dkae289. doi: 10.1093.
PubMed

MEIJS AP, Chaname-Pinedo LE, Deng H, Veldman KT, et al
Association between antimicrobial usage in livestock and antimicrobial resistance in Escherichia coli isolates from human urinary tract infections in the Netherlands, 2009-2020.
J Antimicrob Chemother. 2024 Aug 2:dkae268. doi: 10.1093.
PubMed Abstract available

SCHELLENBERG JJ, Adam HJ, Baxter MR, Karlowsky JA, et al
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21.
J Antimicrob Chemother. 2024 Aug 2:dkae272. doi: 10.1093.
PubMed Abstract available

UNEMO M, Sanchez-Buso L, Golparian D, Jacobsson S, et al
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.
J Antimicrob Chemother. 2024;79:1885-1899.
PubMed Abstract available

SOULIE C, Balde A, Fofana D, Charpentier C, et al
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.
J Antimicrob Chemother. 2024;79:1974-1984.
PubMed Abstract available

BUCZKOWSKA M, Chattaway MA, Jenkins C, Hungerford D, et al
Linking epidemiological and genomic data in cases of enteric fever in England to inform clinical management and public health action.
J Antimicrob Chemother. 2024;79:1811-1819.
PubMed Abstract available

LEE R, Nho D, Cho SY, Park S, et al
Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis.
J Antimicrob Chemother. 2024;79:1998-2007.
PubMed Abstract available

ZHANG X, Zeng W, Kong J, Huang Z, et al
The prevalence and mechanisms of heteroresistance to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
J Antimicrob Chemother. 2024;79:1865-1876.
PubMed Abstract available

DWIBEDY SK, Padhy I, Panda AK, Mohapatra SS, et al
Prevalence of polymyxin-resistant bacterial strains in India: a systematic review and meta-analysis.
J Antimicrob Chemother. 2024;79:1762-1774.
PubMed Abstract available

YANG Q, Li L, Zhao G, Cui Q, et al
Characterization of a multiresistance optrA- and lsa(E)-harbouring unconventional circularizable structure in Streptococcus suis.
J Antimicrob Chemother. 2024 Aug 1:dkae250. doi: 10.1093.
PubMed Abstract available

July 2024

THANASAK J, Wongsurawat T, Jenjaroenpun P, Phumthanakorn N, et al
Characterization of staphylococcal cassette chromosome mec in Staphylococcus haemolyticus ST3 and ST42 isolates from bovine mastitis milk: identification of novel variant in class C1 mec complex.
J Antimicrob Chemother. 2024 Jul 31:dkae242. doi: 10.1093.
PubMed Abstract available

HOWARD A, Green PL, Velluva A, Gerada A, et al
Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.
J Antimicrob Chemother. 2024 Jul 25:dkae230. doi: 10.1093.
PubMed Abstract available

ZHOU X, Yang M, Chen F, Wang L, et al
Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data.
J Antimicrob Chemother. 2024 Jul 19:dkae248. doi: 10.1093.
PubMed Abstract available

SHI Q, Ruan Z, Zhang P, Hu H, et al
Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study.
J Antimicrob Chemother. 2024 Jul 13:dkae227. doi: 10.1093.
PubMed Abstract available

ZHOU H, Buetti N, Perez-Galera S, Bravo-Ferrer J, et al
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
J Antimicrob Chemother. 2024 Jul 11:dkae157. doi: 10.1093.
PubMed Abstract available

SHEEHY J, Scott AP, Henden AS, Kennedy G, et al
Low rates of complications and beta-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy.
J Antimicrob Chemother. 2024 Jul 8:dkae209. doi: 10.1093.
PubMed Abstract available

SWINKELS AF, Berendsen BJA, Fischer EAJ, Zomer AL, et al
Extended period of selection for antimicrobial resistance due to recirculation of persistent antimicrobials in broilers.
J Antimicrob Chemother. 2024 Jul 2:dkae213. doi: 10.1093.
PubMed Abstract available

VALDEZATE S, Medina-Pascual MJ, Villalon P, Garrido N, et al
Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding.
J Antimicrob Chemother. 2024;79:1683-1687.
PubMed Abstract available

DAABOUL D, Osman M, Kassem II, Yassine I, et al
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
J Antimicrob Chemother. 2024;79:1614-1618.
PubMed Abstract available

TEYSSOU E, Soulie C, Fauchois A, Palich R, et al
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type.
J Antimicrob Chemother. 2024;79:1673-1676.
PubMed Abstract available

SCHMID PJ, Forstner P, Kittinger C
Sliding motility of Bacillus cereus mediates vancomycin pseudo-resistance during antimicrobial susceptibility testing.
J Antimicrob Chemother. 2024;79:1628-1636.
PubMed Abstract available

IVANOVA M, Ovsepian A, Leekitcharoenphon P, Seyfarth AM, et al
Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
J Antimicrob Chemother. 2024;79:1657-1667.
PubMed Abstract available

CHEN PJ, Tan MC, Huang WC, Hsu SY, et al
The individual contributions of blaB, blaGOB and blaCME on MICs of beta-lactams in Elizabethkingia anophelis.
J Antimicrob Chemother. 2024;79:1577-1580.
PubMed Abstract available

ELBEDIWI M, Rolff J
Metabolic pathways and antimicrobial peptide resistance in bacteria.
J Antimicrob Chemother. 2024;79:1473-1483.
PubMed Abstract available

WIRDEN M, Pouderoux C, Peytavin G, Abdi B, et al
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.
J Antimicrob Chemother. 2024;79:1706-1707.
PubMed

CADENAS-JIMENEZ I, Saiz-Escobedo L, Carrera-Salinas A, Camprubi-Marquez X, et al
Molecular characterization of macrolide resistance in Haemophilus influenzae and Haemophilus parainfluenzae strains (2018-21).
J Antimicrob Chemother. 2024 Jul 1:dkae214. doi: 10.1093.
PubMed Abstract available

June 2024

CHEN PY, Huang YS, Chuang YC, Wang JT, et al
Implication of genotypes for prognosis of Candida glabrata bloodstream infections.
J Antimicrob Chemother. 2024 Jun 22:dkae200. doi: 10.1093.
PubMed Abstract available

WANG P, Liu S, He X, Miao W, et al
Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection.
J Antimicrob Chemother. 2024 Jun 13:dkae193. doi: 10.1093.
PubMed Abstract available

WESTON G, Giri A, Komarow L, Ge L, et al
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales.
J Antimicrob Chemother. 2024 Jun 12:dkae186. doi: 10.1093.
PubMed Abstract available

CHANCHAITHONG P, Chueahiran S, Pinpimai K, Sroithongkham P, et al
Chromosomal and plasmid localization of ileS2 in high-level mupirocin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus isolated from canine and feline origins.
J Antimicrob Chemother. 2024 Jun 12:dkae172. doi: 10.1093.
PubMed Abstract available

ALTARAWNEH H, Alhomra T, Alharbi M, Fan Y, et al
Synergistic bactericidal activity of a novel dual beta-lactam combination against methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 2024 Jun 4:dkae165. doi: 10.1093.
PubMed Abstract available

RAHMAT ULLAH S, Jamal M, Rahman A, Andleeb S, et al
Comprehensive insights into Klebsiella pneumoniae: unravelling clinical impact, epidemiological trends and antibiotic-resistance challenges.
J Antimicrob Chemother. 2024 Jun 4:dkae184. doi: 10.1093.
PubMed Abstract available

MARURI-ARANSOLO A, Lopez-Causape C, Hernandez-Garcia M, Garcia-Castillo M, et al
In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.
J Antimicrob Chemother. 2024;79:1432-1440.
PubMed Abstract available

LIU M, Wang M, Huang M, Gao Q, et al
Iron efflux by IetA enhances beta-lactam aztreonam resistance and is linked to oxidative stress through cellular respiration in Riemerella anatipestifer.
J Antimicrob Chemother. 2024;79:1385-1396.
PubMed Abstract available

NAVICKAITE I, Holmes H, Dondi L, Randall L, et al
Occurrence and characterization of rmtB-harbouring Salmonella and Escherichia coli isolates from a pig farm in the UK.
J Antimicrob Chemother. 2024;79:1329-1336.
PubMed Abstract available

KOLTE B, Nubel U
Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
J Antimicrob Chemother. 2024;79:1320-1328.
PubMed Abstract available

WANGCHINDA W, Pogue JM, Thamlikitkul V, Leelawattanachai P, et al
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
J Antimicrob Chemother. 2024;79:1372-1379.
PubMed Abstract available

ZOU C, Xu C, Yu R, Shan X, et al
Tandem amplification of a plasmid-borne tet(A) variant gene confers tigecycline resistance in Escherichia coli.
J Antimicrob Chemother. 2024;79:1294-1302.
PubMed Abstract available

NISSIM Y, LaSala PR, Slain D
A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales.
J Antimicrob Chemother. 2024;79:1463-1466.
PubMed

TOLLEY A, Bansal A, Murerwa R, Howard Dicks J, et al
Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.
J Antimicrob Chemother. 2024;79:1248-1269.
PubMed Abstract available

May 2024

GALAL L, Mohamed HS, Dupont C, Conquet G, et al
Circulation of hypervirulent carbapenem-resistant Klebsiella pneumoniae in humans and fish in Djibouti.
J Antimicrob Chemother. 2024 May 22:dkae144. doi: 10.1093.
PubMed

LEE YL, Wang WY, Ko WC, Hsueh PR, et al
Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021.
J Antimicrob Chemother. 2024 May 17:dkae140. doi: 10.1093.
PubMed Abstract available

MILLS RO, Dadzie I, Le-Viet T, Baker DJ, et al
Genomic diversity and antimicrobial resistance in clinical Klebsiella pneumoniae isolates from tertiary hospitals in Southern Ghana.
J Antimicrob Chemother. 2024 May 16:dkae123. doi: 10.1093.
PubMed Abstract available

HARMER CJ, Nelson MJ, Lebreton F, Lertsethtakarn P, et al
Distribution and expression of the aac(6')-Im (aacA16) aminoglycoside resistance gene.
J Antimicrob Chemother. 2024 May 14:dkae136. doi: 10.1093.
PubMed Abstract available

BUZON-MARTIN L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L, et al
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature.
J Antimicrob Chemother. 2024;79:1153-1156.
PubMed Abstract available

PANG X, He Q, Tang K, Huang J, et al
Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
J Antimicrob Chemother. 2024;79:1142-1152.
PubMed Abstract available

CHEN GJ, Cheng CY, Yang CJ, Lee NY, et al
Trends of pre-treatment drug resistance in antiretroviral-naive people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
J Antimicrob Chemother. 2024;79:1157-1163.
PubMed Abstract available

AGHOKENG AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, et al
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
J Antimicrob Chemother. 2024;79:1164-1168.
PubMed Abstract available

GALANI I, Souli M, Katsala D, Karaiskos I, et al
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
J Antimicrob Chemother. 2024;79:1101-1108.
PubMed Abstract available

MALLART E, Guerin F, Amoura A, Le Scouarnec M, et al
Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
J Antimicrob Chemother. 2024;79:1051-1059.
PubMed Abstract available

UNEMO M, Golparian D, Oxelbark J, Kong FYS, et al
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
J Antimicrob Chemother. 2024;79:1006-1013.
PubMed Abstract available

April 2024

WANGCHINDA W, Kaye KS, Patel TS, Albin OR, et al
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended beta-lactam-resistant Pseudomonas aeruginosa.
J Antimicrob Chemother. 2024 Apr 6:dkae104. doi: 10.1093.
PubMed Abstract available

MACFADYEN AC, Paterson GK
Methicillin resistance in Staphylococcus pseudintermedius encoded within novel staphylococcal cassette chromosome mec (SCCmec) variants.
J Antimicrob Chemother. 2024 Apr 2:dkae096. doi: 10.1093.
PubMed Abstract available

March 2024

HARMER CJ, Cahill SM, Kenyon JJ, Hall RM, et al
Aminoglycoside resistance genes in early members of the Acinetobacter baumannii ST78A (SMAL, Italian clone) reside in an IS26-bounded island in the chromosome.
J Antimicrob Chemother. 2024 Mar 26:dkae064. doi: 10.1093.
PubMed Abstract available

GOLPARIAN D, Bazzo ML, Ahlstrand J, Schorner MA, et al
Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
J Antimicrob Chemother. 2024 Mar 22:dkae075. doi: 10.1093.
PubMed Abstract available

PITT-KENDALL R, Sun S, Hughes S, Merrick R, et al
Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016-20.
J Antimicrob Chemother. 2024 Mar 22:dkae073. doi: 10.1093.
PubMed Abstract available

TESSIER E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, et al
Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
PubMed Abstract available

PHILIP A, Oueslati S, Villa F, Pannetier C, et al
Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci.
J Antimicrob Chemother. 2024 Mar 19:dkae062. doi: 10.1093.
PubMed Abstract available

KITTL S, Brodard I, Tresch M, Perreten V, et al
Novel tetracycline resistance gene tet(65) located on a multi-resistance Corynebacterium plasmid.
J Antimicrob Chemother. 2024 Mar 18:dkae066. doi: 10.1093.
PubMed Abstract available

ANJUM MF, Duggett N, Sheldon E, Sharma M, et al
Genomics to detect transmission of livestock-associated methicillin-resistant Staphylococcus aureus from UK pigs in abattoirs during slaughter.
J Antimicrob Chemother. 2024 Mar 5:dkae052. doi: 10.1093.
PubMed Abstract available

REZZOUG I, Emeraud C, Girlich D, Creton E, et al
Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.
J Antimicrob Chemother. 2024;79:683-685.
PubMed

February 2024

VAN HAL SJ, Jensen SO, Tong SYC, Bentley S, et al
Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 2024 Feb 27:dkae048. doi: 10.1093.
PubMed Abstract available

JACQUELINE C, Samper-Cativiela C, Monzon Fernandez S, Ugarte-Ruiz M, et al
Phenotypic and genetic characterization of antimicrobial resistance in Salmonella enterica serovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021.
J Antimicrob Chemother. 2024 Feb 16:dkae029. doi: 10.1093.
PubMed Abstract available

XU Y, Luo X, Yuan B, Liang P, et al
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study.
J Antimicrob Chemother. 2024 Feb 15:dkae035. doi: 10.1093.
PubMed Abstract available

BRENCIANI A, Cinthi M, Coccitto SN, Massacci FR, et al
Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal lineage carrying optrA.
J Antimicrob Chemother. 2024 Feb 15:dkae039. doi: 10.1093.
PubMed Abstract available

HELBO T, Boel JB, Bartels MD, Ahlstrom MG, et al
Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment.
J Antimicrob Chemother. 2024 Feb 9:dkae036. doi: 10.1093.
PubMed Abstract available

SOMAJO S, Nilsson F, Ekelund O, Unemo M, et al
Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry-proof of concept for seven clinically relevant antimicrobials.
J Antimicrob Chemother. 2024 Feb 9:dkae034. doi: 10.1093.
PubMed Abstract available

ROY S, Morita D, Bhattacharya S, Dutta S, et al
Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India.
J Antimicrob Chemother. 2024 Feb 9:dkae024. doi: 10.1093.
PubMed Abstract available

ATAMNA A, Yeshurun M, Shargian L, Raanani P, et al
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.
PubMed

MCHUGH MP, Pettigrew KA, Taori S, Evans TJ, et al
Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
J Antimicrob Chemother. 2024 Feb 7:dkae023. doi: 10.1093.
PubMed Abstract available

AULICINO PC, Sharma S, Truong K, Kukunoor V, et al
Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy.
J Antimicrob Chemother. 2024;79:370-374.
PubMed Abstract available

HU EW, Lu HF, Lin YT, Yang TC, et al
Modulatory role of SmeQ in SmeYZ efflux pump-involved functions in Stenotrophomonas maltophilia.
J Antimicrob Chemother. 2024;79:383-390.
PubMed Abstract available

NDUVA GM, Otieno F, Kimani J, Sein Y, et al
Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
J Antimicrob Chemother. 2024;79:287-296.
PubMed Abstract available

FERRARIS L, Delannoy J, Mazuet C, Diancourt L, et al
Clostridium neonatale antimicrobial susceptibility, genetic resistance determinants, and genotyping: a multicentre spatiotemporal retrospective analysis.
J Antimicrob Chemother. 2024;79:271-279.
PubMed Abstract available

HOSAKA Y, Muraki Y, Kajihara T, Kawakami S, et al
Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
J Antimicrob Chemother. 2024;79:312-319.
PubMed Abstract available

January 2024

FINDLAY J, Bianco G, Boattini M, Nordmann P, et al
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA.
J Antimicrob Chemother. 2024 Jan 31:dkae018. doi: 10.1093.
PubMed

WASAN H, Reeta KH, Gupta YK
Strategies to improve antibiotic access and a way forward for lower middle-income countries.
J Antimicrob Chemother. 2024;79:1-10.
PubMed Abstract available

RITCHIE G, Chorlton SD, Matic N, Bilawka J, et al
WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing.
J Antimicrob Chemother. 2024;79:55-60.
PubMed Abstract available

QI Q, Ghaly TM, Rajabal V, Gillings MR, et al
Dissecting molecular evolution of class 1 integron gene cassettes and identifying their bacterial hosts in suburban creeks via epicPCR.
J Antimicrob Chemother. 2024;79:100-111.
PubMed Abstract available

December 2023

GILL CM, Santini D, Nicolau DP
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
J Antimicrob Chemother. 2023 Dec 28:dkad396. doi: 10.1093.
PubMed Abstract available

XU C, Li Y, Li Y, Huang L, et al
Characterization of an ST38 carbapenem-resistant and highly virulent Escherichia coli carrying conjugatively transferable ColV virulence-resistance and blaNDM-5-positive resistance plasmids.
J Antimicrob Chemother. 2023 Dec 28:dkad403. doi: 10.1093.
PubMed Abstract available

MASSACCI FR, Cucco L, Paniccia M, Luppi A, et al
Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin.
J Antimicrob Chemother. 2023 Dec 28:dkad395. doi: 10.1093.
PubMed Abstract available

ZHAO M, He S, Wen R, Li C, et al
Membrane vesicles derived from Enterococcus faecalis promote the co-transfer of important antibiotic resistance genes located on both plasmids and chromosomes.
J Antimicrob Chemother. 2023 Dec 18:dkad381. doi: 10.1093.
PubMed Abstract available

ERTL NG, Anderson TK, Pardo CJ, Maidment TI, et al
Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.
J Antimicrob Chemother. 2023 Dec 15:dkad373. doi: 10.1093.
PubMed

SHENG Q, Wang N, Zhou Y, Deng X, et al
A new function of thymol nanoemulsion for reversing colistin resistance in Salmonella enterica serovar Typhimurium infection.
J Antimicrob Chemother. 2023;78:2983-2994.
PubMed Abstract available

DJIYOU ABD, Penda CI, Madec Y, Ngondi GD, et al
Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low- or high-level viraemia.
J Antimicrob Chemother. 2023;78:2938-2942.
PubMed Abstract available

UNO S, Gatanaga H, Hayashida T, Imahashi M, et al
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study.
J Antimicrob Chemother. 2023;78:2859-2868.
PubMed Abstract available

MACGOWAN AP, Attwood MLG, Noel AR, Barber R, et al
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance.
J Antimicrob Chemother. 2023;78:2869-2877.
PubMed Abstract available

November 2023

JIANG N, Chen H, Cheng L, Fu Q, et al
Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China.
J Antimicrob Chemother. 2023 Nov 29:dkad365. doi: 10.1093.
PubMed Abstract available

BOU-ANTOUN S, Rokadiya S, Ashiru-Oredope D, Demirjian A, et al
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
J Antimicrob Chemother. 2023;78.
PubMed Abstract available

LEFRANC M, Accoceberry I, Fitton-Ouhabi V, Biteau N, et al
Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
J Antimicrob Chemother. 2023 Nov 22:dkad359. doi: 10.1093.
PubMed Abstract available

NING YT, Sun TS, Dai RC, Luo ZY, et al
Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China.
J Antimicrob Chemother. 2023 Nov 22:dkad356. doi: 10.1093.
PubMed Abstract available

DAI X, Sun J, Zhao W, Wang J, et al
Emergence of a novel ISS1N-optrA-carrying transposon within an integrative and conjugative element from Streptococcus parasuis.
J Antimicrob Chemother. 2023 Nov 15:dkad347. doi: 10.1093.
PubMed Abstract available

LODISE TP, Yucel E, Obi EN, Watanabe AH, et al
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer beta-lactam or beta-lactam/beta-lactamase inhib
J Antimicrob Chemother. 2023 Nov 14:dkad351. doi: 10.1093.
PubMed Abstract available

LI J, Song Y, Deng J, Wang Z, et al
Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animals.
J Antimicrob Chemother. 2023 Nov 7:dkad307. doi: 10.1093.
PubMed Abstract available

LI M, Song C, Hu J, Dong A, et al
Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.
J Antimicrob Chemother. 2023;78:2743-2751.
PubMed Abstract available

FUNICIELLO E, Mula J, Mignone F, Silvestro E, et al
Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis.
J Antimicrob Chemother. 2023;78:2776-2778.
PubMed

October 2023

TRUSWELL A, Lee ZZ, Stegger M, Blinco J, et al
Augmented surveillance of antimicrobial resistance with high-throughput robotics detects transnational flow of fluoroquinolone-resistant Escherichia coli strain into poultry.
J Antimicrob Chemother. 2023 Oct 21:dkad323. doi: 10.1093.
PubMed Abstract available

CALADO NOGUEIRA DE MOURA V, Nguyen MH, Hunkins JJ, Daley CL, et al
In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
J Antimicrob Chemother. 2023 Oct 21:dkad317. doi: 10.1093.
PubMed Abstract available

LEE SY, Gill CM, Nicolau DP
Activity of novel beta-lactam/beta-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
J Antimicrob Chemother. 2023 Oct 16:dkad225. doi: 10.1093.
PubMed Abstract available

CINTHI M, Coccitto SN, Simoni S, Zeni G, et al
Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain.
J Antimicrob Chemother. 2023 Oct 14:dkad321. doi: 10.1093.
PubMed

HALLIDAY C, Kim HY, Tay E, Chen SCA, et al
Exploring synergy between azole antifungal drugs and statins for Candida auris.
J Antimicrob Chemother. 2023 Oct 12:dkad303. doi: 10.1093.
PubMed Abstract available

PICCICA M, Spinicci M, Botta A, Bianco V, et al
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
J Antimicrob Chemother. 2023 Oct 9:dkad298. doi: 10.1093.
PubMed Abstract available

CHEN Y, Yong M, Li M, Si Z, et al
A hydrophilic polyimidazolium antibiotic targeting the membranes of Gram-negative bacteria.
J Antimicrob Chemother. 2023;78:2581-2590.
PubMed Abstract available

MARUAPULA D, Moraka NO, Bareng OT, Mokgethi PT, et al
Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
J Antimicrob Chemother. 2023;78:2489-2495.
PubMed Abstract available

September 2023

Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
J Antimicrob Chemother. 2023 Sep 14:dkad282. doi: 10.1093.
PubMed

JAHA B, Schenkel CD, Jorimann L, Huber M, et al
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
J Antimicrob Chemother. 2023;78:2323-2334.
PubMed Abstract available

VAN HAL SJ, Whiley DM, Le T, Ray S, et al
Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.
J Antimicrob Chemother. 2023;78:2203-2208.
PubMed Abstract available

July 2023

BENDER JK, Baufeld E, Becker K, Claus H, et al
CHROMAgar LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.
J Antimicrob Chemother. 2023 Jul 20:dkad218. doi: 10.1093.
PubMed Abstract available

June 2023

SIMJEE S, Tice G
The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens.
J Antimicrob Chemother. 2023 Jun 9:dkad183. doi: 10.1093.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum